BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 16713688)

  • 1. Differentiation between field and vaccine strain of bluetongue virus serotype 16.
    Monaco F; Cammà C; Serini S; Savini G
    Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of genome segments 2, 7 and 10 of bluetongue viruses serotype 2 for differentiation between field isolates and the vaccine strain.
    Bréard E; Sailleau C; Coupier H; Mure-Ravaud K; Hammoumi S; Gicquel B; Hamblin C; Dubourget P; Zientara S
    Vet Res; 2003; 34(6):777-89. PubMed ID: 14746772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.
    Batten CA; Maan S; Shaw AE; Maan NS; Mertens PP
    Virus Res; 2008 Oct; 137(1):56-63. PubMed ID: 18598726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Italian field and South African vaccine strains of bluetongue virus serotype 2 using real-time PCR.
    Orrù G; Santis PD; Solinas F; Savini G; Piras V; Caporale V
    J Virol Methods; 2004 Dec; 122(1):37-43. PubMed ID: 15488618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
    Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
    Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular differentiation of field and vaccine strains of bluetongue virus serotype 2 using the real-time polymerase chain reaction and fluorescene resonance energy transfer hybridisation probes.
    de Santis P; Orrù G; Solinas F; Piras V; Savini G; Caporale V
    Vet Ital; 2004; 40(4):572-6. PubMed ID: 20422589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VP2-segment sequence analysis of some isolates of bluetongue virus recovered in the Mediterranean basin during the 1998-2003 outbreak.
    Potgieter AC; Monaco F; Mangana O; Nomikou K; Yadin H; Savini G
    J Vet Med B Infect Dis Vet Public Health; 2005 Nov; 52(9):372-9. PubMed ID: 16283915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of real-time RT-PCR as a rapid molecular approach for differentiation of field and vaccine strains of bluetongue virus serotypes 2 and 9.
    Elia G; Savini G; Decaro N; Martella V; Teodori L; Casaccia C; Di Gialleonardo L; Lorusso E; Caporale V; Buonavoglia C
    Mol Cell Probes; 2008 Feb; 22(1):38-46. PubMed ID: 17693055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of bluetongue virus in Portugal during 2004-2006 outbreak.
    Barros SC; Ramos F; Luís TM; Vaz A; Duarte M; Henriques M; Cruz B; Fevereiro M
    Vet Microbiol; 2007 Sep; 124(1-2):25-34. PubMed ID: 17521832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
    Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
    Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bluetongue: characterization of virus types by reverse transcription-polymerase chain reaction.
    Zientara S; Bréard E; Sailleau C
    Dev Biol (Basel); 2006; 126():187-96; discussion 326-7. PubMed ID: 17058494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First evidence of bluetongue virus serotype 16 in Croatia.
    Listes E; Monaco F; Labrović A; Paladini C; Leone A; Di Gialleonardo L; Cammá C; Savini G
    Vet Microbiol; 2009 Jul; 138(1-2):92-7. PubMed ID: 19376658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
    Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
    Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bluetongue virus serotypes 1 and 4 in Sardinia during autumn 2012: new incursions or re-infection with old strains?
    Lorusso A; Sghaier S; Carvelli A; Di Gennaro A; Leone A; Marini V; Pelini S; Marcacci M; Rocchigiani AM; Puggioni G; Savini G
    Infect Genet Evol; 2013 Oct; 19():81-7. PubMed ID: 23838283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
    Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
    Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serogrouping of United States and some African serotypes of bluetongue virus using RT-PCR.
    Aradaib IE; Mohamed ME; Abdalla TM; Sarr J; Abdalla MA; Yousof MA; Hassan YA; Karrar AR
    Vet Microbiol; 2005 Dec; 111(3-4):145-50. PubMed ID: 16280207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.